In both BC and other cancer contexts, elevated levels of insulin and IGF-1 have been implicated in tumorigenesis via activation of mitogenic and anti-apoptotic signaling pathways, such as Ras-MAPK and PI3K-Akt [91,92,93]. This evidence concerns the gene IGF1 and breast cancer.